Randomized Phase Ii Study Of Concurrent Gefitinib And Chemotherapy Versus Sequential Alternating Gefitinib And Chemotherapy In Previously Untreated Non-Small Cell Lung Cancer (Nsclc) With Sensitive Egfr Mutations: Nej005/Tcog0902.

Annals of Oncology(2014)

引用 98|浏览8
暂无评分
摘要
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFRmutations: NEJ005/TCOG0902 S. Sugawara1, S. Oizumi2*, K. Minato3, T. Harada4, A. Inoue5, Y. Fujita6, M. Maemondo7, H. Yoshizawa8, K. Ito9, A. Gemma10, M. Nishitsuji11, M. Harada12, H. Isobe13, I. Kinoshita14, S. Morita15, K. Kobayashi16, K. Hagiwara17, M. Kurihara18, T. Nukiwa19 & on behalf of North East Japan Study Group and Tokyo Cooperative Oncology Group Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai; First Department of Medicine, Hokkaido University School of Medicine, Sapporo; Department of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma; Center for Respiratory Diseases, JCHO Hokkaido Hospital, Sapporo; Department of Respiratory Medicine, Tohoku University Hospital, Sendai; Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa; Department of Respiratory Medicine, Miyagi Cancer Center, Natori; Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata; Department of Respiratory Medicine, Niigata City General Hospital, Niigata; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Graduate School of Medicine, Tokyo; Department of Respiratory Medicine, Ishikawa Prefectural Central Hospital, Kanazawa; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo; Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo; Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Sapporo; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka; Department of Respiratory Medicine, Saitama Medical University, Saitama; Tokyo Cooperative Oncology Group, Tokyo; Japan Anti-Tuberculosis Association, Tokyo, Japan
更多
查看译文
关键词
non-small cell lung cancer,first-line,EGFR-TKI,chemotherapy,combination,EGFR mutation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要